Privia Health Group Files 8-K

TL;DR

PRVA filed an 8-K for a Reg FD disclosure and exhibits. Standard update.

AI Summary

Privia Health Group, Inc. filed an 8-K on August 29, 2025, reporting an event on August 28, 2025. The filing is primarily a Regulation FD Disclosure and includes Financial Statements and Exhibits. No specific financial transactions or material events are detailed in the provided text, but it indicates a standard reporting update.

Why It Matters

This filing indicates Privia Health Group, Inc. is making a regulatory disclosure and submitting financial exhibits, which is a standard but important part of public company reporting.

Risk Assessment

Risk Level: low — The filing appears to be a routine disclosure and submission of exhibits, with no immediately apparent negative or positive material events described.

Key Players & Entities

• Privia Health Group, Inc. (company) — Registrant
• August 28, 2025 (date) — Date of earliest event reported
• August 29, 2025 (date) — Date of Report
• Delaware (jurisdiction) — State of incorporation
• 001-40365 (company_id) — Commission File Number
• 950 N. Glebe Rd., Suite 700 (address) — Principal Executive Offices
• Arlington, Virginia (location) — Principal Executive Offices Location
• 571-366-8850 (phone_number) — Registrant's telephone number

FAQ

Key Financial Figures

• $0.01 — ange on which registered Common Stock, $0.01 par value per share PRVA The Nasdaq Glo
• $113 — idance for full-year 2025 to a range of $113-$116 million. A copy of the press relea
• $116 million — e for full-year 2025 to a range of $113-$116 million. A copy of the press release is attache

Filing Documents

• prva-20250828.htm (8-K) — 26KB
• ex-991prpriviaacos2024mssp.htm (EX-99.1) — 23KB
• privialogo.jpg (GRAPHIC) — 8KB
• 0001759655-25-000096.txt ( ) — 182KB
• prva-20250828.xsd (EX-101.SCH) — 2KB
• prva-20250828_lab.xml (EX-101.LAB) — 22KB
• prva-20250828_pre.xml (EX-101.PRE) — 13KB
• prva-20250828_htm.xml (XML) — 3KB

01. Regulation FD Disclosure

Item 7.01. Regulation FD Disclosure On August 28, 2025, Privia Health Group, Inc. (the "Company") issued a press release announcing its 2024 performance results in the Medicare Shared Savings Program and preliminarily increasing its Adjusted EBITDA guidance for full-year 2025 to a range of $113-$116 million. A copy of the press release is attached hereto as Exhibit 99.1. The materials are attached as Exhibit 99.1 to this Current Report on Form 8-K, are incorporated into this Item 7.01 by reference and are available on our investor relations website at ir.priviahealth.com. This information may be amended or updated at any time and from time to time through another Current Report on Form 8-K, a later company filing, or other means. The information in this Current Report on Form 8-K (including the exhibit) is furnished pursuant to Item 7.01 and shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. This Current Report on Form 8-K will not be deemed an admission as to the materiality of any information in the Report that is required to be disclosed solely by Regulation FD.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibit: Exhibit No. Description 99.1 Privia Health Group, Inc. Press Release Dated August 28, 2025 104 Cover Page Interactive Data File (formatted as Inline XBRL)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. PRIVIA HEALTH GROUP, INC. Date: August 28, 2025 By: /s/ David Mountcastle Name: David Mountcastle Title: Executive Vice President, Chief Financial Officer and Authorized Officer

View Full Filing

View this 8-K filing on SEC EDGAR